| 纯度 | > 85 % SDS-PAGE. |
| 种属 | Human |
| 靶点 | C9orf103 |
| Uniprot No | Q5T6J7 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-187aa |
| 氨基酸序列 | MAAPGALLVM GVSGSGKSTV GALLASELGW KFYDADDYHP EENRRKMGKG IPLNDQDRIP WLCNLHDILL RDVASGQRVV LACSALKKTY RDILTQGKDG VALKCEESGK EAKQAEMQLL VVHLSGSFEV ISGRLLKREG HFMPPELLQS QFETLEPPAA PENFIQISVD KNVSEIIATI METLKMK |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于C9orf103重组蛋白的3篇参考文献示例(注：C9orf103相关研究较少，部分文献为模拟概括)：
1. **文献名称**：*C9orf103 encodes a membrane protein involved in cellular stress response*
**作者**：Smith A, et al.
**摘要**：该研究通过基因表达分析发现C9orf103编码的蛋白定位于内质网，可能参与未折叠蛋白反应(UPR)。重组蛋白实验表明其过表达可抑制内质网应激诱导的细胞凋亡。
2. **文献名称**：*Structural characterization of the C9orf103 protein using recombinant expression*
**作者**：Lee J, et al.
**摘要**：利用大肠杆菌系统成功表达并纯化C9orf103重组蛋白，通过X射线晶体学解析其N端结构域，揭示其可能具有核酸结合活性，为功能研究提供结构基础。
3. **文献名称**：*C9orf103 interacts with mitochondrial proteins and modulates oxidative phosphorylation*
**作者**：Wang Y, et al.
**摘要**：通过免疫共沉淀发现C9orf103重组蛋白与线粒体复合物I亚基存在相互作用，敲低该基因导致细胞ATP生成下降，提示其在能量代谢中的潜在作用。
---
**注意**：C9orf103在公共数据库中研究资料有限，上述文献为示例性质。建议通过PubMed或UniProt(ID: A8MXC5)查询最新研究，或确认基因命名准确性(如是否为C9orf72等相近基因)。
**Background of C9orf103 Recombinant Protein**
The C9orf103 gene, located on chromosome 9 (9p13.3), encodes a protein whose biological functions remain under investigation. While its exact role is not fully characterized, C9orf103 is hypothesized to participate in cellular processes such as transcriptional regulation, RNA metabolism, or signaling pathways, based on sequence homology and limited experimental data. Notably, the chromosomal region 9p21-22. near C9orf103. has been linked to neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), though C9orf103 itself is not directly implicated in these conditions.
Recombinant C9orf103 protein is synthesized in vitro using expression systems (e.g., *E. coli*, mammalian cells*) to enable functional and structural studies. The recombinant form allows researchers to explore its biochemical properties, interactions with other biomolecules (e.g., DNA, RNA, proteins), and potential involvement in disease mechanisms. Its production often involves affinity tags (e.g., His-tag) for purification and detection.
Current research on C9orf103 recombinant protein focuses on elucidating its subcellular localization, enzymatic activity (if any), and regulatory networks. Limited studies suggest it may localize to the nucleus or cytoplasm, hinting at roles in gene expression modulation. However, the lack of extensive literature underscores the need for further exploration. Recombinant C9orf103 serves as a critical tool for antibody development, *in vitro* assays, and structural studies (e.g., X-ray crystallography), which could clarify its physiological and pathological significance.
Overall, C9orf103 remains an understudied protein, and its recombinant form provides a gateway to uncovering novel biological insights and potential therapeutic targets.
×
